A COVID clash: How to proceed when IACUCs and IBCs disagree?

被引：0
|
作者：
Silverman, Jerald [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA
来源：
LAB ANIMAL | 2021年 / 50卷 / 01期
关键词：
D O I：
10.1038/s41684-020-00686-8
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [41] When should the clinician suspect a drug-induced blood dyscrasia, and how should he proceed?
    Heimpel, H
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1996, 57 : 11 - 15
  • [42] Examining the dynamics of decision making when designing curriculum in partnership with students: How should we proceed?
    Sohr, Erin Ronayne
    Gupta, Ayush
    Johnson, Brandon J.
    Quan, Gina M.
    PHYSICAL REVIEW PHYSICS EDUCATION RESEARCH, 2020, 16 (02):
  • [43] A preliminary look at how psychologists identify, evaluate, and proceed when faced with possible multiple relationship dilemmas
    Lamb, DH
    Catanzaro, SJ
    Moorman, AS
    PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE, 2004, 35 (03) : 248 - 254
  • [44] When Polls Disagree: How Competitive Results and Methodological Quality Shape Partisan Perceptions of Polls and Electoral Predictions
    Kuru, Ozan
    Pasek, Josh
    Traugott, Michael W.
    INTERNATIONAL JOURNAL OF PUBLIC OPINION RESEARCH, 2020, 32 (03) : 586 - 603
  • [45] When and How Will the Epidemic of COVID-19 End?
    Zhang, Shuo
    Yang, Zhen
    Chen, Zhen-Lin
    Li, Zhuo-Ning
    Yue, Shi-Jun
    Li, Jia-Jia
    Yan, Fei
    Xu, Ding-Qiao
    Tang, Yu-Ping
    AGING AND DISEASE, 2022, 13 (03): : 641 - 646
  • [46] Toward a Universal Definition of Post-COVID-19 Condition-How Do We Proceed?
    Pan, Daniel
    Pareek, Manish
    JAMA NETWORK OPEN, 2023, 6 (04)
  • [47] Whole Genome Sequencing in Routine Hematologic Samples: How to Proceed Analyses Best When Germline Controls Are Missing?
    Hutter, Stephan
    Nadarajah, Niroshan
    Meggendorfer, Manja
    Kern, Wolfgang
    Haferlach, Torsten
    Haferlach, Claudia
    BLOOD, 2018, 132
  • [48] When Business and Science Clash, How Can We Avoid Harming Patients? The Case of AVOID-HF
    Mark, Daniel B.
    O'Connor, Christopher M.
    JACC-HEART FAILURE, 2016, 4 (02) : 106 - 108
  • [49] Antibodies for COVID-19-which, when and how long?
    Theoharides, T. C.
    Lauritano, D.
    Ronconi, G.
    Calvisi, V.
    Conti, P.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (02): : 417 - 422
  • [50] When, how, why and whom for there will be an "after" Covid-19?
    Tognoni, Gianni
    ASSISTENZA INFERMIERISTICA E RICERCA, 2020, 39 (03) : 147 - 153
12345